CHILDHOOD CANCER REPOSITORY

Powered by

Alex's Lemonade Stand Foundation

Neuroblastoma PDCLs OPEN

Cell lines ending in “h” are established and grown in 5% O2. Cells ending in “h2” are established and grown in 2% O2. Cells established and grown in serum-free neurobasal media will end with “nb”.

The defination for the abbreviation are given below the table. Please scroll all the way down.

Please click at the top logo to return to home page.

dbGaP info icon Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program - Neuroblastoma
dbGaP Study Accession: phs003163.v1.p1

dbGaP info icon Childhood Cancer Data Initiative (CCDI): CCDI Pediatric In Vivo Testing Program - Leukemia
dbGaP Study Accession: phs003164.v2.p1

PDXs in our Childhood Cancer Repository which can be found in the CCDI PIVOT data are marked with a dbGaP info icon dbGaP info icon in the table below.

RequestCell Line2%5%20%NB 5%NB 20%
SMS-SAN--✓--
SMS-MSN--✓--
SMS-LHN--✓--
SMS-KCNR--✓--
SMS-KCN--✓--
SMS-KANR--✓--
SMS-KAN--✓--
SK-N-FI--✓--
SK-N-BE(2)--✓--
SK-N-BE(1)--✓--
NB-Ebc1 dbGaP info icon--✓--
NB-1643 dbGaP info icon--✓--
LA-N-6--✓--
LA-N-5--✓--
LA-N-1--✓--
FU-NB-2006-✓✓--
CHLA-102-✓✓--
CHLA-103-✓✓--
CHLA-104-✓✓--
CHLA-105-✓✓--
CHLA-108--✓--
CHLA-109-✓✓--
CHLA-11--✓--
CHLA-110--✓--
CHLA-111b--✓--
CHLA-116--✓--
CHLA-119--✓--
CHLA-12--✓--
CHLA-120--✓--
CHLA-122--✓--
CHLA-123--✓--
CHLA-124--✓--
CHLA-127--✓--
CHLA-13--✓--
CHLA-132--✓--
CHLA-134--✓--
CHLA-136-✓✓--
CHLA-137-✓✓--
CHLA-138-✓✓--
CHLA-139-✓✓--
CHLA-14-✓✓--
CHLA-140--✓--
CHLA-144--✓--
CHLA-145--✓--
CHLA-146--✓--
CHLA-15--✓--
CHLA-150-✓✓--
CHLA-151--✓--
CHLA-152--✓--
CHLA-16--✓--
CHLA-160--✓--
CHLA-161--✓--
CHLA-162--✓--
CHLA-165--✓--
CHLA-17--✓--
CHLA-171-✓✓--
CHLA-172-✓✓--
CHLA-174--✓--
CHLA-175--✓--
CHLA-179--✓--
CHLA-18--✓--
CHLA-183--✓--
CHLA-188L--✓--
CHLA-19--✓--
CHLA-20--✓--
CHLA-225-✓✓--
CHLA-24--✓--
CHLA-247--✓--
CHLA-253--✓--
CHLA-255--✓--
CHLA-27--✓--
CHLA-28--✓--
CHLA-29--✓--
CHLA-30--✓--
CHLA-32--✓--
CHLA-34--✓--
CHLA-40--✓--
CHLA-41--✓--
CHLA-42--✓--
CHLA-43--✓--
CHLA-44--✓--
CHLA-46--✓--
CHLA-51--✓--
CHLA-52--✓--
CHLA-53--✓--
CHLA-54--✓--
CHLA-58--✓--
CHLA-60--✓--
CHLA-61--✓--
CHLA-66--✓--
CHLA-70-✓✓--
CHLA-78--✓--
CHLA-79 dbGaP info icon--✓--
CHLA-8--✓--
CHLA-81--✓--
CHLA-83--✓--
CHLA-90--✓--
CHLA-95--✓--
COG-N-261--✓--
COG-N-263--✓--
COG-N-265 --✓--
COG-N-269--✓--
COG-N-276--✓--
COG-N-278--✓--
COG-N-289--✓--
COG-N-291--✓--
COG-N-293--✓--
COG-N-294--✓--
COG-N-295--✓--
COG-N-296--✓--
COG-N-297--✓--
COG-N-299--✓--
COG-N-303--✓--
COG-N-305--✓--
COG-N-312--✓--
COG-N-316--✓--
COG-N-318--✓--
COG-N-320--✓--
COG-N-321--✓--
COG-N-322--✓--
COG-N-323--✓--
COG-N-324--✓--
COG-N-325--✓--
COG-N-327-✓✓--
COG-N-328h-✓---
COG-N-331--✓--
COG-N-333--✓--
COG-N-334-✓✓--
COG-N-346h-✓---
COG-N-347--✓--
COG-N-349-✓✓--
COG-N-353-✓✓--
COG-N-354h-✓---
COG-N-367-✓✓--
COG-N-372h-✓✓--
COG-N-381h-✓---
COG-N-386h-✓---
COG-N-387h-✓---
COG-N-396h-✓---
COG-N-399-✓✓✓-
COG-N-415-✓✓✓-
COG-N-421-✓✓--
COG-N-440✓✓✓✓-
COG-N-442h-✓---
COG-N-443h-✓---
COG-N-445✓✓✓--
COG-N-452✓✓✓✓-
COG-N-453✓✓✓✓-
COG-N-462h✓✓---
COG-N-469h-✓---
COG-N-470✓✓✓--
COG-N-471hnb---✓-
COG-N-473h-✓✓✓✓
COG-N-474✓✓✓--
COG-N-475h-✓-✓-
COG-N-476-✓✓✓✓
COG-N-478-✓✓✓-
COG-N-480h2✓--✓-
COG-N-482h-✓---
COG-N-490h-✓---
COG-N-491h✓✓-✓-
COG-N-496✓✓✓✓-
COG-N-497✓✓-✓-
COG-N-500--✓--
COG-N-504-✓✓--
COG-N-505-✓---
COG-N-507h-✓---
COG-N-508h-✓---
COG-N-509hnb-✓---
COG-N-511h2✓--✓-
COG-N-512--✓--
COG-N-513✓✓✓--
COG-N-514-✓✓--
COG-N-515-✓✓--
COG-N-518-✓✓--
COG-N-519✓✓✓-✓
COG-N-529✓✓✓--
COG-N-531h-✓✓--
COG-N-532-✓---
COG-N-534-✓✓--
COG-N-540-✓✓--
COG-N-542h-✓✓--
COG-N-544-✓✓--
COG-N-546h-✓---
COG-N-548-✓---
COG-N-549-✓✓--
COG-N-553✓✓✓--
COG-N-554-✓✓--
COG-N-556-✓✓--
COG-N-557-✓✓✓-
COG-N-561-✓✓--
COG-N-562-✓---
COG-N-563--✓--
COG-N-564h✓✓---
COG-N-571--✓--
COG-N-573✓✓✓--
COG-N-574-✓✓--
COG-N-575-✓---
COG-N-577-✓✓✓-
COG-N-578-✓-✓-
COG-N-579h-✓-✓-
COG-N-581h-✓---
COG-N-582h-✓---
COG-N-585-✓✓✓-
COG-N-586-✓✓✓-
COG-N-587h-✓---
COG-N-590-✓✓--
COG-N-592-✓✓--
COG-N-599-✓✓--
COG-N-600-✓✓✓-
COG-N-602-✓✓--
COG-N-603✓✓✓--
COG-N-615-✓✓--
COG-N-618✓✓✓--
COG-N-619✓✓✓--
COG-N-623✓✓✓--
COG-N-625hnb---✓-
COG-N-626h✓✓---
COG-N-628✓✓✓--
COG-N-631h---✓-
COG-N-636✓✓✓--
COG-N-645✓✓✓--
COG-N-651h✓✓---
COG-N-660hnb---✓-
COG-N-672✓✓✓--
COG-N-682-✓✓--
COG-N-683✓✓✓--
COG-N-694--✓--
COG-N-696h-✓---
COG-N-697h-✓---
COG-N-700✓✓✓--
COG-N-707-✓✓--
COG-N-708-✓---
COG-N-711h-✓---
COG-N-716h-✓-✓-
COG-N-719✓✓-✓-
COG-N-721h-✓---
COG-N-731-✓✓--
COG-N-732-✓---
COG-N-733✓✓---
COG-N-740✓✓✓--
COG-N-742h-✓---
COG-N-743h✓✓---
COG-N-748-✓✓--
COG-N-750--✓--
COG-N-752✓✓✓--
COG-N-764-✓✓--
COG-N-765✓✓✓--
COG-N-786-✓---
COG-N-791-✓---
COG-N-793h-✓---
COG-N-818--✓--
COG-N-848--✓--
COG-N-813✓-✓--
COG-N-815✓✓✓✓-
COG-N-823✓-✓--
COG-N-853✓✓✓--
COG-N-854✓✓✓--
JAYMB0408✓✓✓--
Felix dbGaP info icon-✓✓--

1 - Phase of therapy for the patient at the time the specimen used to derive the cell line was obtained
Dx (Diagnosis): cell lines derived from samples of patients prior to treatment
PD (Progressive Disease): cell lines derived from samples of patients who relapsed after chemotherapy
PD-BMT: cell lines derived from samples of patients who relapsed after chemotherapy and bone marrow transplantation
PD-PM: cell lines derived from samples of post-mortem patients who relapsed after chemotherapy

2 -MYCN oncogene amplification
N: MYCN Non-Amplified
A: MYCN Amplified

3 - TP53 gene function
F: Functional
N: Non-Functional

4 - EWS/FLI1 Status
FLI1: friend leukemia insertion - chromosome 11, t(11;22)
ERG: ets-related gene - chromosome 21, t(21;22)

ALK mutation

WT: Wild Type

TMM:Telomere Maintenance mechanism

✓ = Available/available upon request

SQ- subcutaneous injection

TV- intravenous (tail vein)

EST- ever shorter telomeres, i.e. telomerase and ALT negative

TERT+- telomerase positive

ALT - alternate lengthening of telomeres, C-circle positive